bioRxivMicrobiologyPreprint
The phenotypic landscape of the mycobacterial cell
Nadia HerreraiD, Horia TodoriD, Lili M. KimiD, Hannah N. Burkhart, Evan BillingsiD, Allison FayiD, Theodore C. WarneriD, So Young LeeiD, Natalie Y. Sayegh, Barbara BoschiD, James CheniD, Laura L. KiesslingiD, Michael S. GlickmaniD, Filippo ManciaiD, Jeremy M. RockiD, Carol A. GrossiD
Abstract
The Mycobacteriales are an order of diverse bacteria that thrive in many environmental and host-associated niches. Because the most notorious member of this clade, Mycobacterium tuberculosis, is a major human pathogen, research on Mycobacteriales has focused on pathogenesis, and, as a consequence, many fundamental aspects of Mycobacterial biology remain understudied. Here, we address this gap by performing a genome-wide CRISPRi chemical genomics screen using a diverse set of >35 antibiotics, detergents, and other anti-microbials predominantly targeting the cell envelope of Mycobacterium smegmatis, a saprophytic model Mycobacterium. We highlight new information derived from this screen, including the identification of novel functions for previously uncharacterized conserved and essential genes (in mycolic acid and arabinogalactan synthesis), the discovery of a new drug scaffold/protein target pair, and insights into the mechanism of action of two commonly used antibiotics. These data are also a valuable resource for the mycobacterial research community, as they provide thousands of novel phenotypes for uncharacterized genes and meaningful phenotypic correlations between annotated and uncharacterized genes.
- organism: bacteria (other)
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- research focus: cell type annotation
- approach: genetic perturbation / CRISPR
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis
Matthew B. McNeil, Laura M. Keighley, … Gregory Murray Cook·Molecular MicrobiologyPeer-reviewed·Aug 4, 2021
- Validation of DXS as an attractive drug target in mycobacteria
T Maila, M Nicolaai, … Gabriel T. Mashabela·bioRxiv·Nov 4, 2024
- A chemical-genetic map of the pathways controlling drug potency in Mycobacterium tuberculosis
S. Li, N. C. Poulton, … J. M. Rock·bioRxiv·Nov 27, 2021
- Utilisation of the Prestwick Chemical Library (R) to identify drugs that inhibit the growth of Mycobacteria
L. J. Alderwick, P. Kanvatirth, … J. Bacon·bioRxiv·Jun 28, 2018
- Mycobacterial cell division arrest and smooth-to-rough envelope transition using CRISPRi-mediated genetic repression systems
Vanessa Point, Wafaa Achache, … Pierre Santucci·FEBS Open BioPeer-reviewed·Nov 30, 2025
- Emergence of resistance to the antiparasitic selamectin in Mycobacterium smegmatis is improbable and contingent on cell wall integrity
José Manuel Ezquerra-Aznárez, Henrich Gašparovič, … Santiago Ramón‐García·Microbiology SpectrumPeer-reviewed·Apr 8, 2025